Clinical Trial Update: Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial comparing liraglutide to insulin in patients with type 2 diabetes to assess liver fat fraction in nonalcoholic fatty liver disease and nonalcoholi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Victoza (Liraglutide)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED